TRANSENTERIX INC - COM NEW (TRXC)

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
39,276,318
Share change
+3,013,749
Total reported value
$47,914,188
Put/Call ratio
64%
Price per share
$1.22
Number of holders
81
Value change
+$590,085
Number of buys
52
Number of sells
30

Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q2 2016

As of 30 Jun 2016, TRANSENTERIX INC - COM NEW (TRXC) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,276,318 shares. The largest 10 holders included Aisling Capital LLC, SV Life Sciences Advisers, LLC, JPMORGAN CHASE & CO, StepStone Group LP, AQR CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MASTERS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.